Alpine Global Management, LLC Nkarta, Inc. Transaction History

Alpine Global Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $122,058 - $250,602	23,161 New	23,161 $136,000
Q2 2023 Aug 06, 2024	BUY	$2.19 - $5.17 $124,878 - $294,803	57,022 New	57,022 $124,000
Q2 2023 Nov 21, 2023	BUY	$2.19 - $5.17 $124,878 - $294,803	57,022 New	57,022 $124,000
Q2 2023 Aug 14, 2023	BUY	$2.19 - $5.17 $124,878 - $294,803	57,022 New	57,022 $124,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $123M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.